Novo Nordisk CEO Mike Doustdar said on Monday as many as 1.5 million patients in the U.S. may be using compounded versions of ...
Fagron, the leading global player in pharmaceutical compounding, is pleased to announce the completion of University ...
CDSCO introduces guidelines for compounding offences, streamlining compliance for pharma firms and minimizing court appearances for minor contraventions.
The pitfalls of the Central Drugs Standard Control Organization's guidelines to compound minor drug violations are them regressing into a ‘pay and pass’ scheme and the CDSCO’s transparency ...
The Week US on MSN
What is a compounding pharmacy?
Customizing medications can be lifesaving and also dangerous. Understand the advantages and disadvantages of Compounding Pharmacies.
Fungal infections kill millions of people each year, and modern medicine is struggling to keep up. But researchers at ...
Roasted coffee may do more than wake you up—it could help control blood sugar. Researchers discovered several new coffee ...
A new drug candidate shows promise by reversing cognitive decline in advanced Alzheimer's disease by restoring brain balance ...
Hims & Hers Health, Inc. is rated a Buy with strong subscriber growth and rising revenue per subscriber. Learn more about ...
In a Monday interview with CNBC's Jim Cramer, Novo Nordisk CEO Mike Doustdar suggested the new pill format of the ...
Hims & Hers trades at FWD EV/Sales of 3.45x and FWD EV/EBITDA of 25.85x, with FY2030 targets implying further upside for ...
Explore the impact of drug discovery automation in 2026, addressing complexity and improving decision-making across ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback